All > Massachusetts Investigators

Minnie Abromowitch

Children's Hospital

Boston, Massachusetts - 02115 (617-355-6058)

CLINICAL TRIALS 1
CONDITIONS3
INTERVENTIONS7
SINCE2004

Risk-Group Classification of Patients With Newly Diagnosed Acute Lymphoblastic Leukemia

January 2004 - December 2007

Leukemia

Leukemia, Lymphoid

Precursor Cell Lymphoblastic Leukemia-Lymphoma

Laboratory Biomarker Analysis

Biopsy

Polymorphism Analysis

Immunologic Technique

Fluorescence In Situ Hybridization

Dna Ploidy Analysis

Chromosomal Translocation Analysis

Learn about TrialX Patient Recruitment services

Massimo Loda, MD

Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute

Suzanne Shusterman

Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute Childrens Hospital Boston, Dana-Farber Cancer Institute. Children's Hospital Boston

Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute Dana-Farber Cancer Institute Dana Farber / Brigham and Women's Cancer Center Dana-Farber Cancer Institute, Center for Neuro-Oncology Dana-Farber Cancer Instiute

Lewis B. Silverman, MD

Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute Dana-Farber Cancer Institute and Children's Hospital Dana Faber Cancer Institute, Children's Hospital, Dept. of Pediatric Oncology Children's Hospital Boston Dana-Farber Cancer Institute

Minnie Abromowitch

Children's Hospital

Massimo Loda, MD

Suzanne Shusterman

Patrick Y. Wen, MD

Lewis B. Silverman, MD

Kay Kehoe, Coordinator

Jennifer Brown, MD

Rachel A. Freedman

Edwin P. Alyea, MD

F. Stephen Hodi, MD

Beth A. Overmoyer, MD, FACP